Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Clinical Pharmacology Study of JNS010 (Paliperidone Palmitate) in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedA Multicenter, Open-label, Clinical Pharmacology Trial to Determine the Pharmacokinetics, Tolerability, and Safety of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
This study was withdrawn before enrollment.
Location not clearly listedA Multi-center, Open-label Clinical Pharmacology Trial to Investigate the Pharmacokinetics, Tolerability, and Safety of Brexpiprazole Once-weekly (QW) Formulation Administered as Single and Multiple Oral Doses in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In Tokyo
A Clinical Study Evaluating the Efficacy and Safety of CreNeuroS CNS Herbal Nutrition Capsules for Participants With Mild Depressive Disorder Comorbid With Anxiety Disorder
This study has finished and is no longer accepting participants.
In NanchangResearchers are comparing SEP-4199 CR 200 mg, SEP-4199 CR 400 mg and placebo to find out how the approaches affect depression symptoms in people with bipolarity type I during a depressive episode.
This study ended early.
Multiple locations, including Huntsville
Researchers compared light therapy and placebo to find out how the approaches affected depression symptoms in people with bipolarity.
This study has finished and is no longer accepting participants.
In BeijingThis study evaluated the safety and effectiveness of Trazodone for people with depression.
This study has finished and is no longer accepting participants.
In ChangshaA Randomized, Open-Label, Single Dose, Cross-over Study of Gastric Emptying Rate: SEP-363856 vs Prior Antipsychotic Standard of Care in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockAn Open-Label, Fixed Sequence, Multiple Dose Study of Glucose and Insulin Associated Parameters: SEP-363856 vs Prior Antipsychotic (PA) Standard of Care in Subjects With Schizophrenia Suffering From Metabolic Dysregulation
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockA Double-Blind, Randomized, Multiple Dose Study of Weight Associated Parameters: SEP-363856 vs Prior Antipsychotic (PA) Standard of Care in Subjects With Schizophrenia Suffering From Metabolic Dysregulation
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockResearchers studied SEP-363856, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimResearchers compared SEP-363856 and placebo to find out how the approaches affected anxiety symptoms in adults with an anxiety condition.
This study has finished and is no longer accepting participants.
Multiple locations, including HuntsvilleWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.